Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.4.16.2 (
PCP
)
3,761
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
1. Effects of
PCP
at the frog neuromuscular junction were studied in vitro in sciatic nerve sartorius muscle of the toad Pleurodema-thaul. 2. Within the concentration 0.003-0.1 mM,
PCP
caused a dose-time-dependent block of evoked transmitter release acompanied by an increase in the rate of spontaneous quantal release. 3.
PCP
induced an increase in miniature endplate potential (MEPP) frequency and it was not antagonized in a Ca2(+)-free medium, indicating that it does not depend upon Ca2+ influx from the external medium, but may act by releasing Ca2+ from intraterminal stores. 4. The present data, together with previous results concerning
PCP
at eighth sympathetic ganglia indicate that 3,4-diaminopyridine (
3,4-DAP
) counteracts the effects of
PCP
on synaptic transmission. This result suggests that
PCP
interfering Ca2+ influx occurs during depolarization of motor nerve terminals.
...
PMID:The effects of pentachlorophenol (PCP) at the toad neuromuscular junction. 198 Aug 76